Tecnicians working at sequencers
Wednesday, September 5, 2012

By Ashley DeVine, Staff Writer

By the end of October, the Advanced Technology Research Facility (ATRF) will be one of the few facilities in the world to house all of the latest DNA sequencing technologies.

People at a microscope
Tuesday, September 4, 2012

By Nancy Parrish, Staff Writer

Ulrich Baxa, Ph.D., director of the Electron Microscopy Laboratory (EML), enjoys finally having his staff all in one place.

“Our lab is now all in one location, as compared to our previous situation, with two different locations,” he said. “This will make daily work much easier, in particular for me since I am able to have an office next to the other EML staff.”

Technicians using microscopes.
Monday, September 3, 2012

By Nancy Parrish, Staff Writer

For the first time, the Nanotechnology Characterization Laboratory (NCL) is under one roof, as a result of their move to the Advanced Technology Research Facility (ATRF).  The move is expected to streamline their work as well as provide greater opportunities for collaboration with other researchers, both internal and external.

Two men standing in front of a building.
Sunday, September 2, 2012

By Nancy Parrish, Staff Writer

The physical space of the Advanced Technology Research Facility (ATRF) is designed to encourage collaborations, both internal and external. Of the 330,000 square feet of space at the new facility, nearly 40,000 have been set aside for collaborations between the Frederick National Laboratory for Cancer Research (FNL) and outside partners in an arrangement that brings together scientists and specialists from government, industry, academia, and the nonprofit sectors in support of the research of NCI.

new building
Saturday, September 1, 2012

By Nancy Parrish, Staff Writer

At a March 2010 gathering at the construction site of the Advanced Technology Research Facility (ATRF), Craig Reynolds, Ph.D., associate director of the National Cancer Institute (NCI), noted that the facility would be a place where public–private partnerships will produce the next generation of diagnostics and treatments for cancer and AIDS. The completion of the facility, he said, “is anticipated by the 1.5 million Americans who get cancer every year….They anxiously await this construction” (News & Views, April 2010, page 3).

Pages